1Clinical Immunology Department, Istituto di Medicina Interna e Immunoallergologia, Università di Firenze, Italy.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Local nasal immunotherapy (LNIT) and subcutaneous immunotherapy (SIT) reduce allergic rhinitis symptoms by inducing T-cell tolerance. Both treatments decrease T-cell proliferation, offering a mechanism for clinical improvement in allergic patients.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: